Last year, regulatory agencies in the U.S., Japan, China, and the U.K. all approved Eli Lilly’s new Alzheimer’s anti-amyloid drug Kisunla. Based on the status of drugs in the development pipeline, we don’t expect there to be another new Alzheimer’s drug in 2025. But, there are several promising drug candidates with Phase 3 trials wrapping […]
Tomorrow’s treatment today.
If you are interested in learning more or participating in any of our studies, please fill out the form below and our office will get back to you within 1-2 business days.
All K2 locations will be closed from December 24, 2024 – January 5, 2025. We will reopen on January 6, 2025. In the meantime, please check out our website to learn more about our clinical research trials, our teams, and ways you can join our growing team.
Wishing you and your families a Happy Holiday Season!
Melissa Belardo, is a certified family nurse practitioner (FNP-BC), joins K2 Medical Research with more than a decade of clinical experience. She has served as an investigator in over 20 trials. Prior to clinical research, she held roles in gastroenterology, hepatology, and nurse education.
Melissa’s academic background includes a Bachelor of Science in Nursing from Adventist University, followed by a master’s degree in Family Nurse Practitioner from Georgetown University.
Melissa is a native of the US Virgin Islands’ and is fluent in both English and Spanish; Melissa has lived in central Florida for the past twenty years. When she’s not at work, you can find her volunteering at her local church and spending time with family.